Hyeongi Kim
7PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 09, 2026
Oncolytic adenovirus in combination with PD-L1-targeted radioimmunotherapy exerts synergistic antitumor effect against pancreatic cancer.A-Rum Yoon, Seungyoun Kim, Ji Yi
|Aug 06, 2020
Relaxin-expressing oncolytic adenovirus induces remodeling of physical and immunological aspects of cold tumor to potentiate PD-1 blockade.Bo-Kyeong Jung, Hae Young Ko, Hyunji Kang
|May 15, 2020
Inhibition of HIF-1α by Atorvastatin During 131I-RTX Therapy in Burkitt's Lymphoma Model.Eun-Ho Kim, Hae Young Ko, A Ram Yu
|Nov 14, 2019
Combination Radioimmunotherapy Strategies for Solid Tumors.Javeria Zaheer, Hyeongi Kim, Yong-Jin Lee
|Sep 25, 2019
Comparison between Fractionated Dose and Single Dose of Cu-64 Trastuzumab Therapy in the NCI-N87 Gastric Cancer Mouse Model.Javeria Zaheer, Hyeongi Kim, Yong-Jin Lee
|Apr 25, 2019
Selection Criteria for Determination of Optimal Reconstruction Method for Cu-64 Trastuzumab Dosimetry on Siemens Inveon PET Scanner.Seonhwa Lee, Hyeongi Kim, Ye-Rin Kang
Pageof 2
